Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOLDS: high- versus standard-dose Syntocinon for delay in labour
ISRCTN99841044Phase 3Completed
- Sponsor
- Birmingham Women's and Children's NHS Foundation Trust
- Start
- Mar 2017
- Modality
- Recombinant Proteins and Enzymes, Peptides
01
Overview
Phase 3, randomised, double-blind trial of oxytocin in labor dysfunction, sponsored by Birmingham Women's and Children's NHS Foundation Trust. Primary endpoint: Incidence of caesarean section. Started Mar 2017; status: completed.
02
Drugs
oxytocin
03
Conditions
labor dysfunction
Beyond the preview
Go deeper on ISRCTN99841044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN99841044.